Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Real-world assessment of effectiveness and safety of candesartan in migraine prevention: Results of the French FHU InovPain registry
S. Ferrao-Malheiro; R. Fabre; M. Lanteri-MinetShow moreShow less
Pain Department, UR2CA-PIN, FHU InovPain, CHU de Nice, Côte d’Azur University, Nice, France; Public Health Department, FHU InovPain, UR2CA – RESPECT, CHU de Nice, Côte Azur University, Nice, France; Inserm U1107 Migraine and Trigeminal Pain, Auvergne University, Clermont-Ferrand, FranceShow moreShow less
Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study
R. Demeret; D. Vieles Marais; E. Treiner; B. Acket; V. Fabry; T. Levade; L. Nogueira; J.-C. Pages; P. CintasShow moreShow less
Service de neurologie, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France; Service de biologie cellulaire et cytologie, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France; Laboratoire d’immunologie, institut fédératif de biologie, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France; Pôle neurosciences, centre SLA, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France; Laboratoire de biochimie, institut fédératif de biologie, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, France; Laboratoire de biologie cellulaire et cytologie, institut fédératif de Biologie, CHU de Toulouse-Purpan, place du Docteur Baylac, 31300 Toulouse, FranceShow moreShow less
Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry
C. Maisonnier; J.-P. Cottier; G. Charbonnier; A. Monaya; J. Rhein; M. Gaudron; M. Haba; N. Deschamps; A. Nasri; B. de Toffol; I.L. MaldonadoShow moreShow less
CHRU de Tours, Tours, France; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032 Tours, France; CHU de Besançon, Besançon, France; CHU de Cayenne Andrée Rosemon, Cayenne, French Guiana; Inserm CIC1424, Antilles, French Guiana; UA17 Santé des populations en Amazonie, Cayenne, French GuianaShow moreShow less
Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?
A. Marques; C. Lambert; P. Derost; C. Beal; B. Debilly; I. Rieu; F. DurifShow moreShow less
Department of Neurology, CNRS, Pascal Institute, CHU de Clermont-Ferrand, Université Clermont-Auvergne, 63000 Clermont-Ferrand, France; Biostatistics Unit, DRCI, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, FranceShow moreShow less
Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives
A. Launay; A. Baudouin; C. Gonthier; M. Brachet; A. Matysiak; S. Vanneste; L. TaconnatShow moreShow less
Centre de recherche sur la cognition et l’apprentissage (CeRCA), UMR-CNRS 7295, université de Tours, Tours, France; Centre mémoire de ressources et de recherche (CMRR), CHRU de Tours, Tours, France; Institut de psychologie, LMC2 UR 7536, université Paris-Cité, Paris, France; Laboratoire de psychologie des Pays de la Loire (LPPL UR 4638), Nantes université, 44000 Nantes, France; Institut universitaire de France, Paris, FranceShow moreShow less
Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families
H. Gharebaghian; M. Ravanbod; A. Ghasemi; A. Asghar Okhovat; S. Nafissi; A. AlaviShow moreShow less
Neuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Neurology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran; Neurology Department, Tehran University of Medical Sciences, Shariati Hospital, Tehran, IranShow moreShow less
FAQ
How long does REVUE NEUROLOGIQUE take to review a manuscript?
As of 2026-11-19, CrushSCI has 10 complete review records for REVUE NEUROLOGIQUE. The fastest paper went from submission to acceptance in 70 days (Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry, received 2026-03-14, accepted 2026-05-23); the slowest took 310 days. The average is 185.8 days and the median is 197 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
